{"title":"Ruthenium and platinum-based anticancer metallotherapeutics from the perspectives of photodynamic therapy and bioimaging applications","authors":"Sowmiya Ganesan, Angappan Sheela","doi":"10.1007/s11696-024-03684-z","DOIUrl":null,"url":null,"abstract":"<div><p>Bioimaging is a well-known process for visualizing biological substances or biological pathways in the human body at a molecular level without any intrusion. It has been used in various domains biological of chemistry, drug discovery, and disease detection, due to its potential application attributes of high resolution, high sensitivity, high selectivity, and low cost. In recent years, the transition metal-based luminescent probes or photosensitizers have a distinctive feature in optical bioimaging and photodynamic therapy, in in vivo and in vitro, as compared to other types of probes and have a strong influence on discovering biological analytes. Photodynamic therapy, a non-systemic treatment, has attracted significant attention for its ability to localize the disease. This depends on the nature of the photosensitizers, light, and reactive oxygen species (ROS), produced through electron transport or energy transfer pathways. In PDT, a photosensitizer (PS) gets activated on exposure to light of a specific wavelength and provides energy to molecular oxygen on the tissue surfaces. This generates reactive oxygen species such as superoxide, singlet oxygen, and hydroxyl radicals causing damage to cellular membranes, lipids, proteins, and DNA. Further, it also results in cell death via apoptosis and necrosis on targeted cancer cells. The current review provides a literature overview on bioimaging and PDT applications of reported ruthenium and platinum complexes acting as luminescent probes. The extensively studied ligands, in this context, are bipyridine, phenanthroline, porphyrin, BODIPY, and ferrocene. These complexes have been studied for their potential anticancer activity against different cancer cells in both light and dark conditions. In addition, these probes also possess excellent photophysical characteristics of intense emission, with significant Stokes shifts, extended lifetimes, controllable toxicity, and excellent photostability.</p><h3>Graphical abstract</h3>\n<div><figure><div><div><picture><source><img></source></picture></div></div></figure></div></div>","PeriodicalId":513,"journal":{"name":"Chemical Papers","volume":null,"pages":null},"PeriodicalIF":2.2000,"publicationDate":"2024-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chemical Papers","FirstCategoryId":"92","ListUrlMain":"https://link.springer.com/article/10.1007/s11696-024-03684-z","RegionNum":4,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Engineering","Score":null,"Total":0}
引用次数: 0
Abstract
Bioimaging is a well-known process for visualizing biological substances or biological pathways in the human body at a molecular level without any intrusion. It has been used in various domains biological of chemistry, drug discovery, and disease detection, due to its potential application attributes of high resolution, high sensitivity, high selectivity, and low cost. In recent years, the transition metal-based luminescent probes or photosensitizers have a distinctive feature in optical bioimaging and photodynamic therapy, in in vivo and in vitro, as compared to other types of probes and have a strong influence on discovering biological analytes. Photodynamic therapy, a non-systemic treatment, has attracted significant attention for its ability to localize the disease. This depends on the nature of the photosensitizers, light, and reactive oxygen species (ROS), produced through electron transport or energy transfer pathways. In PDT, a photosensitizer (PS) gets activated on exposure to light of a specific wavelength and provides energy to molecular oxygen on the tissue surfaces. This generates reactive oxygen species such as superoxide, singlet oxygen, and hydroxyl radicals causing damage to cellular membranes, lipids, proteins, and DNA. Further, it also results in cell death via apoptosis and necrosis on targeted cancer cells. The current review provides a literature overview on bioimaging and PDT applications of reported ruthenium and platinum complexes acting as luminescent probes. The extensively studied ligands, in this context, are bipyridine, phenanthroline, porphyrin, BODIPY, and ferrocene. These complexes have been studied for their potential anticancer activity against different cancer cells in both light and dark conditions. In addition, these probes also possess excellent photophysical characteristics of intense emission, with significant Stokes shifts, extended lifetimes, controllable toxicity, and excellent photostability.
众所周知,生物成像是一种在分子水平上对人体内的生物物质或生物通路进行无损可视化的过程。由于具有高分辨率、高灵敏度、高选择性和低成本等潜在应用特性,它已被用于化学、药物发现和疾病检测等多个生物领域。近年来,与其他类型的探针相比,过渡金属基发光探针或光敏剂在体内和体外光学生物成像和光动力疗法方面具有鲜明的特点,在发现生物分析物方面具有很大的影响力。光动力疗法是一种非系统性治疗方法,因其能够定位疾病而备受关注。这取决于光敏剂、光和通过电子传输或能量转移途径产生的活性氧(ROS)的性质。在光导疗法中,光敏剂(PS)在特定波长的光线照射下被激活,并为组织表面的分子氧提供能量。这会产生活性氧,如超氧化物、单线态氧和羟基自由基,对细胞膜、脂质、蛋白质和 DNA 造成破坏。此外,它还会导致目标癌细胞通过凋亡和坏死而死亡。本综述概述了有关作为发光探针的钌和铂复合物的生物成像和光导放疗应用的文献。在这方面被广泛研究的配体包括联吡啶、菲罗啉、卟啉、BODIPY 和二茂铁。这些复合物被研究用于在明暗条件下对不同癌细胞的潜在抗癌活性。此外,这些探针还具有极佳的光物理特性:强烈的发射、显著的斯托克斯位移、较长的寿命、可控的毒性和出色的光稳定性。
Chemical PapersChemical Engineering-General Chemical Engineering
CiteScore
3.30
自引率
4.50%
发文量
590
期刊介绍:
Chemical Papers is a peer-reviewed, international journal devoted to basic and applied chemical research. It has a broad scope covering the chemical sciences, but favors interdisciplinary research and studies that bring chemistry together with other disciplines.